Lupin files Spiriva in US and Enbrel in EU

Lupin has realised plans to file an abbreviated new drug application (ANDA) for generic Spiriva (tiotropium bromide) in the US, as the Indian firm continues to advance its pipeline of complex generics, including respiratory drugs, and biosimilars.

More from Earnings

More from Business